- Qian, P., hong Peng,, & Ye, X. (2019). Interstitial pneumonia induced by cyclophosphamide: A case report and review of the literature. Respiratory medicine case reports, 26, 212-214.
- John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021). COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts. Immunological Reviews, 302(1), 228-240.
- Siddiqui, N., Husain, A., Chaudhry, L., Alam, M. S., Mitra, M., & Bhasin, P. S. (2011). Pharmacological and pharmaceutical profile of valsartan: a review. Journal of Applied Pharmaceutical Science, (Issue), 12-19.
- Al-Harbi, N. O., Imam, F., Al-Harbi, M. M., Ansari, M. A., Zoheir, K. M., Korashy, H. M. & Ahmad, S. F. (2016). Dexamethasone attenuates LPS-induced acute lung injury through inhibition of NF-κB, COX-2, and pro-inflammatory mediators. Immunological Investigations, 45(4), 349-369.
- Abdel-Latif, G. A., Elwahab, A. H. A., Hasan, R. A., ElMongy, N. F., Ramzy, M. M., Louka, M. L., & Schaalan, M. F. (2020). A novel protective role of sacubitril/valsartan in cyclophosphamide induced lung injury in rats: impact of miRNA-150-3p on NF-κB/MAPK signaling trajectories. Scientific reports, 10(1), 1-17.
- Kiernan, John. (2015). Histological and histochemical methods. Scion publishing ltd, fifth edition 155-170.
- Bancroft, J. D. S., Layton, C., &. Suvarna, K (Eds.). (2018). Bancroft's theory and practice of histological techniques E-Book. Elsevier health sciences 301-319.
- Gunnar F. Nordberg, Bruce A. Fowler, Monica Nordberg and Lars T. Friberg. (2007): Handbook on the Toxicology of Metals. Science Direct 6th edition , pp 39-64
- Emsley, R., Dunn,, & White, I. R. (2010). Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Statistical methods in medical research, 19(3), 237-270.
- Tripathi, D. N. & Jena, G. B. (2008). Astaxanthin inhibits cytotoxic and genotoxic efects of cyclophosphamide in mice germ cells. Toxicol‑ ogy 248, 96–103.
- El-Sheikh, A. A., Morsy, M. A. & Okasha, A. M. (2017). Inhibition of NF-kappaB/TNF-alpha pathway may be involved in the protective efect of resveratrol against cyclophosphamide-induced multi-organ toxicity. Immunopharmacol. Immunotoxicol. 39, 180–187.
- El-Kashef, D. H. (2018). Role of venlafaxine in prevention of cyclophosphamide-induced lung toxicity and airway hyperactivity in rats. Environmental Toxicology and Pharmacology, 58, 70-76.
- Paulsen, C., Truong, T. H., Garcia, F. J., Homann, A., Gupta, V., Leonard, S. E., & Carroll, K. S. (2012). Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nature chemical biology, 8(1), 57-64.
- Li, L., Li, Q., Wei, L., Wang, Z., Ma, W., Liu, F., & Qian, Y. (2019). Dexamethasone combined with berberine is an effective therapy for bleomycin‑induced pulmonary fibrosis in rats. Experimental and Therapeutic Medicine, 18(4), 2385-2392.
- Schiller, H., Fernandez, I. E., Burgstaller, G., Schaab, C., Scheltema, R. A., Schwarzmayr, T., & Mann, M. (2015). Time‐and compartment‐resolved proteome profiling of the extracellular niche in lung injury and repair. Molecular systems biology, 11(7), 819.
- Liu, T., De Los Santos, F. G., & Phan, S. H. (2017). The bleomycin model of pulmonary fibrosis. Fibrosis: Methods and Protocols, 27-42.
- Carthy, M. (2018). TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders. Journal of cellular physiology, 233(1), 98-106.
- Knudsen, L., Ruppert, C., & Ochs, M. (2017). Tissue remodelling in pulmonary fibrosis. Cell and Tissue Research, 367, 607-626.
- Penke, L. R., & Peters-Golden, M. (2019). Molecular determinants of mesenchymal cell activation in fibroproliferative diseases. Cellular and Molecular Life Sciences, 76, 4179-4201.
- Cameli, P., Carleo, A., Bergantini, L., Landi, C., Prasse, A., & Bargagli, E. (2020). Oxidant/antioxidant disequilibrium in idiopathic pulmonary fibrosis pathogenesis. Inflammation, 43, 1-7.
- Vavrinec, P., H Henning, R., W Landheer, S., Wang, Y., E Deelman, L., PE van Dokkum, R., & Buikema, H. (2014). Vildagliptin restores renal myogenic function and attenuates renal sclerosis independently of effects on blood glucose or proteinuria in Zucker diabetic fatty rat. Current Vascular Pharmacology, 12(6), 836-844.
- Rasooli, R., Pourgholamhosein, F., Kamali, Y., Nabipour, F., & Mandegary, A. (2018). Combination therapy with pirfenidone plus prednisolone ameliorates paraquat-induced pulmonary fibrosis. Inflammation, 41, 134-142.
- Kakugawa, T., Mukae, H., Hayashi, T., Ishii, H., Abe, K., Fujii, T., ... & Kohno, S. (2004). Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis. European Respiratory Journal, 24(1), 57-65.
- Ismail,, Hossain, M., Tanu, A. R., & Shekhar, H. U. (2015). Effect of spirulina intervention on oxidative stress, antioxidant status, and lipid profile in chronic obstructive pulmonary disease patients. BioMed research international, 201-215.
- Bellaye, P., Yanagihara, T., Granton, E., Sato, S., Shimbori, C., Upagupta, C., & Kolb, M. (2018). Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension. European Respiratory Journal, 52(2) 134-150.
- Chen, J. F., Ni, F., Pan, M. M., Liu, H., Xu, M., Zhang, M. H., & Liu, B. C. (2013). Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats. American Journal of Physiology-Renal Physiology, 304(6), F676-F685.
- Li, V. C. (2003). On engineered cementitious composites (ECC) a review of the material and its applications. Journal of advanced concrete technology, 1(3), 215-230.
- Judge and(2015)."Neprilysin inhibition in chronic kidney disease." Nephrology Dialysis Transplantation 30.5 :738-743.
- Salama RM, Abd Elwahab AH, Abd-Elgalil MM, Elmongy NF, Schaalan MF. (2020) .LCZ696 (sacubitril/valsartan) protects against cyclophosphamide-induced testicular toxicity in rats: Role of neprilysin inhibition and lncRNA TUG1 in ameliorating apoptosis. Toxicology 437:152439-152443.
- Paragliola, M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017). Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis. International journal of molecular sciences, 18(10), 2201-2209.
|